Global Automated External Defibrillator Market Outlook 2026-2031 - Rising Incidence Of Sudden Cardiac Arrest Drives Growth
Dublin, Aug. 27, 2026 (GLOBE NEWSWIRE) -- The "Automated External Defibrillator - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
Automated External Defibrillator Market to Reach USD 2.52 Billion by 2031 as Public-Access Programs Expand
The global automated external defibrillator market is projected to grow from USD 1.65 billion in 2025 to USD 1.76 billion in 2026 before reaching USD 2.52 billion by 2031. The market is forecast to expand at a compound annual growth rate of 7.44% from 2026 to 2031, supported by the rising incidence of sudden cardiac arrest, government-funded public-access defibrillation programs and continued advances in AED technology.
Sudden Cardiac Arrest Drives Global AED Demand
The increasing prevalence of sudden cardiac arrest remains a major driver of automated external defibrillator market growth. The United States records approximately 350,000 out-of-hospital sudden cardiac arrest events annually, while survival rates decline by about 10% for every minute defibrillation is delayed. Updated American Heart Association guidelines issued in 2025 shortened recommended response intervals and expanded pediatric protocols, encouraging greater AED deployment in schools, childcare centers and sports venues.
Public-health agencies are also increasing CPR and AED awareness. During CPR Awareness Week, India's Ministry of Health engaged more than 747,000 citizens and delivered physical training to over 606,000 participants. Aging populations are raising baseline cardiac risk across Japan and Europe, while Asia-Pacific's middle-income economies are experiencing rapid growth in cardiovascular disease alongside gaps in emergency-response infrastructure.
Government Programs Accelerate Public-Access AED Installations
Government-backed public-access defibrillation initiatives are creating substantial opportunities for AED manufacturers and emergency-care providers. China installed more than 64,000 public-access devices in 2024, while Beijing committed to deploying 2,000 connected cabinets equipped with GPS telemetry. In the United Kingdom, GBP 1 million, equivalent to approximately USD 1.27 million, was allocated in 2025 to install 2,000 AEDs in underserved communities.
Public-building mandates in France, Germany and Italy are supporting predictable installation and replacement cycles. In the United States, public-access legislation, federal grants and procurement programs continue to strengthen AED availability in urban and rural communities.
Ownership Costs Remain a Key Market Restraint
High acquisition and maintenance expenses continue to limit adoption among small institutions, nonprofit organizations, volunteer fire departments and clinics. Entry-level AEDs typically cost between USD 849 and USD 1,795, but batteries, electrode pads, cabinets and training can significantly increase five-year ownership costs. Administrative requirements associated with grant applications can also discourage smaller organizations from pursuing available funding. Additional market challenges include limited reimbursement and liability concerns in emerging economies.
Fully Automatic and Biphasic AEDs Gain Momentum
Semi-automatic AEDs accounted for 58.24% of the automated external defibrillator market in 2025, reflecting their established use in professional training and clinical environments. Fully automatic AEDs are expected to record a 9.78% CAGR through 2031 as airports, stadiums, schools and other public venues prioritize systems designed to minimize intervention delays. Hospitals are expected to retain strong demand for semi-automatic models because they provide greater clinical oversight.
Biphasic waveform AEDs represented 91.11% of market revenue in 2025 and are forecast to grow by 9.45% annually. Their expansion is supported by higher first-shock efficacy, impedance-adjusted energy delivery and lower risk of tissue damage. Monophasic AEDs remain present in older hospital inventories and lower-income markets, although falling prices for biphasic systems are accelerating their replacement.
North America Leads as Asia-Pacific Records Fastest Growth
North America generated 44.22% of global automated external defibrillator market revenue in 2025. The region benefits from mature public-access regulations, established emergency medical services and federal funding initiatives. Canada and Mexico offer additional growth potential as provincial authorities, municipalities and private employers expand AED installations.
Asia-Pacific is forecast to register the fastest regional CAGR of 9.34% through 2031. China, Japan and South Korea are increasing AED availability across public facilities, schools and commercial buildings. India also presents considerable long-term potential, although the absence of comprehensive federal mandates and liability protections may limit near-term adoption.
Europe is expected to maintain steady growth as public-access requirements support demand in the United Kingdom, France, Germany and Italy. Environmental regulations governing batteries and electronic waste are increasing compliance costs while encouraging longer-life batteries, recycling initiatives and equipment upgrades. Emerging programs in Gulf Cooperation Council countries, Brazil and other developing markets could create further opportunities as governments evaluate the impact of public-access AED networks on cardiac arrest survival rates.
Key Topics Covered
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Sudden Cardiac Arrest (SCA)
4.2.2 Government-Funded Public Access Defibrillation (PAD) Programs
4.2.3 Technological Shift to Biphasic & Impedance-Compensated Waveforms
4.2.4 Integration Of AEDs into Smart-City IoT Emergency Networks
4.2.5 Corporate ESG Mandates Adding AED Coverage to Workplace HSE KPIs
4.2.6 Subscription-Based "AED-As-A-Service" Lowering CAPEX Barriers
4.3 Market Restraints
4.3.1 High Acquisition & Maintenance Cost for Small Institutions
4.3.2 Limited Reimbursement & Liability Concerns in Emerging Markets
4.3.3 Supply-Chain Dependence on Lithium Cells Facing EU/US Sourcing Rules
4.3.4 End-Of-Life Environmental Compliance (Battery & Pad Waste)
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value in USD)
5.1 By Product Type
5.1.1 Semi-Automatic AEDs
5.1.2 Fully-Automatic AEDs
5.2 By Technology
5.2.1 Biphasic Waveform AEDs
5.2.2 Monophasic Waveform AEDs
5.3 By Modality
5.3.1 Professional-Use AEDs
5.3.2 Public-Access AEDs
5.4 By End User
5.4.1 Hospitals & Clinics
5.4.2 Emergency Medical Services (EMS)
5.4.3 Public Access Locations
5.4.4 Home Care
5.4.5 Others (Training Institutions, Corporate Wellness)
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 France
5.5.2.3 United Kingdom
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.3.1 A.M.I. Italia
6.3.2 Asahi Kasei (ZOLL Medical)
6.3.3 Avive Solutions
6.3.4 Beijing M&B Electronic
6.3.5 BPL Medical Technologies
6.3.6 Cardiac Science (CSI)
6.3.7 CU Medical Systems
6.3.8 Defibtech LLC
6.3.9 Fukuda Denshi
6.3.10 HeartSine Technologies
6.3.11 Koninklijke Philips N.V.
6.3.12 Mediana Co. Ltd.
6.3.13 Metrax GmbH (Corpuls)
6.3.14 Nihon Kohden Corporation
6.3.15 Progetti Srl
6.3.16 Rapid Response Revival
6.3.17 Schiller AG
6.3.18 Shenzhen Mindray Bio-Medical
6.3.19 Shenzhen XFT
6.3.20 Stryker (Physio-Control)
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment